Literature DB >> 27803102

Commentary on microRNA Fingerprint in Human Epithelial Ovarian Cancer.

Marilena V Iorio1, Carlo M Croce2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27803102     DOI： 10.1158/0008-5472.CAN-16-2637

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  4 in total

1.  A miRNA signature assessing ovarian cancer prognosis.

Authors:  Marina Bagnoli; Sandro Pignata; Delia Mezzanzanica
Journal:  Oncoscience       Date:  2016-12-02

Review 2.  Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management.

Authors:  Pavol Zubor; Peter Kubatka; Karol Kajo; Zuzana Dankova; Hubert Polacek; Tibor Bielik; Erik Kudela; Marek Samec; Alena Liskova; Dominika Vlcakova; Tatiana Kulkovska; Igor Stastny; Veronika Holubekova; Jan Bujnak; Zuzana Laucekova; Dietrich Büsselberg; Mariusz Adamek; Walther Kuhn; Jan Danko; Olga Golubnitschaja
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

3.  Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer.

Authors:  Rosanna Sestito; Roberta Cianfrocca; Piera Tocci; Laura Rosanò; Andrea Sacconi; Giovanni Blandino; Anna Bagnato
Journal:  Commun Biol       Date:  2020-11-13

4.  High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma.

Authors:  Arash Adamnejad Ghafour; Demet Akdeniz Odemis; Seref Bugra Tuncer; Busra Kurt; Mukaddes Avsar Saral; Seda Kilic Erciyas; Ozge Sukruoglu Erdogan; Betul Celik; Pinar Saip; Hulya Yazici
Journal:  J Ovarian Res       Date:  2021-10-10       Impact factor: 4.234
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.